You have 9 free searches left this month | for more free features.

BMS-986322

Showing 26 - 50 of 817

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Heart Failure Trial in Worldwide (BMS-986435, Placebo)

Not yet recruiting
  • Heart Failure
  • Atlanta, Georgia
  • +40 more
Nov 3, 2023

Multiple Myeloma Trial in Boston (BMS-986393, Alnuctamab, Mezigdomide)

Not yet recruiting
  • Multiple Myeloma
  • Boston, Massachusetts
  • +1 more
Nov 2, 2023

Advanced Solid Tumors Trial in Worldwide (BMS-986449, Nivolumab)

Not yet recruiting
  • Advanced Solid Tumors
  • Los Angeles, California
  • +19 more
May 25, 2023

Healthy Volunteers Trial (BMS-986278, Drospirenone/Ethinyl Estradiol)

Not yet recruiting
  • Healthy Volunteers
  • (no location specified)
Aug 3, 2023

Alzheimer's Disease Trial in New Haven, West Bend (BMS-984923, Placebo)

Recruiting
  • Alzheimer's Disease
  • New Haven, Connecticut
  • +1 more
Mar 27, 2023

Healthy Volunteers Trial (BMS-986196, Caffeine, Montelukast)

Not yet recruiting
  • Healthy Volunteers
  • (no location specified)
May 1, 2023

Healthy Participants Trial (BMS-986278, Itraconazole, Gemfibrozil)

Not yet recruiting
  • Healthy Participants
  • (no location specified)
Jun 27, 2023

Healthy Participants Trial (BMS-986447, Placebo)

Not yet recruiting
  • Healthy Participants
  • (no location specified)
Feb 27, 2023

Healthy Female Volunteers Trial (BMS-986196, Loestrin)

Not yet recruiting
  • Healthy Female Volunteers
  • (no location specified)
May 26, 2023

Healthy Participants Trial in Lenexa (BMS-986172, Placebo)

Completed
  • Healthy Participants
  • Lenexa, Kansas
    ICON Plc (Legacy PRA)
Jun 2, 2022

Healthy Participants, Primary Sjögren's Syndrome Trial in Berlin (BMS-986325, Placebo for BMS-986325)

Recruiting
  • Healthy Participants
  • Primary Sjögren's Syndrome
  • BMS-986325
  • Placebo for BMS-986325
  • Berlin, Germany
    Local Institution - 0001
Jul 11, 2022

Migraine Trial in United States (BMS-927711 (CGRP Antagonist))

Completed
  • Migraine
  • BMS-927711 (CGRP Antagonist)
  • Glendale, California
  • +3 more
Dec 15, 2022

Relapsed/Refractory Non-Hodgkin Lymphoma Trial in Duarte, Amsterdam (BMS-986458, Rituximab)

Not yet recruiting
  • Relapsed/Refractory Non-Hodgkin Lymphoma
  • Duarte, California
  • +1 more
Oct 13, 2023

Healthy Participants Trial in Madison (BMS-986369)

Recruiting
  • Healthy Participants
  • Madison, Wisconsin
    Labcorp Clinical Research Unit - Madison
Nov 27, 2022

Healthy Trial in Chengdu (JNJ-70033093)

Completed
  • Healthy
  • Chengdu, China
    West China Hospital, Si Chuan University
Jan 3, 2023

Healthy Volunteers Trial in Madison ([14C] BMS-986278, Kinevac®)

Completed
  • Healthy Volunteers
  • Madison, Wisconsin
    Covance - Clinical Pharmacology Services - Madison
Jun 1, 2022

Healthy Volunteers Trial ([14C]BMS-986419)

Not yet recruiting
  • Healthy Volunteers
  • (no location specified)
Apr 27, 2023

Relapsed or Refractory Multiple Myeloma Trial in Worldwide (CC-92480, Carfilzomib, Dexamethasone)

Recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Mobile, Alabama
  • +130 more
Jan 27, 2023

Urinary Bladder Tumors Trial in Worldwide (Nivolumab, BCG, BMS-986205)

Completed
  • Urinary Bladder Neoplasms
  • Nivolumab
  • +2 more
  • Los Angeles, California
  • +88 more
Jan 24, 2023

Healthy Participants Trial (BMS-986278, Sildenafil, Placebo)

Not yet recruiting
  • Healthy Participants
  • (no location specified)
Jan 12, 2023

Lupus Trial in Worldwide (BMS-986326, Placebo for BMS-986326)

Not yet recruiting
  • Lupus
  • Tampa, Florida
  • +10 more
Aug 23, 2023

NSCLC Trial in Worldwide (BMS-986315, Nivolumab, Pemetrexed)

Not yet recruiting
  • NSCLC
  • Boise, Idaho
  • +12 more
Oct 17, 2023

Advanced Cancer, Melanoma, NSCLC Trial in Worldwide (BMS-986205, Nivolumab, Ipilimumab)

Completed
  • Advanced Cancer
  • +2 more
  • Tucson, Arizona
  • +46 more
Aug 18, 2022